Stimuli-responsive In situ gelling system for nose-to-brain drug delivery
The diagnosis and treatment of neurological ailments always remain an utmost challenge for
research fraternity due to the presence of BBB. The intranasal route appeared as an …
research fraternity due to the presence of BBB. The intranasal route appeared as an …
[HTML][HTML] Recent advances in intranasal liposomes for drug, gene, and vaccine delivery
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …
produced from cholesterol and phospholipids. Recently, liposomes have been widely …
Recent progress in nanocarriers for direct nose to brain drug delivery
Nose to brain drug delivery is considered as a viable option to deliver various therapeutic
agents with low cerebral bioavailability bypass blood-brain barrier (BBB). The drug …
agents with low cerebral bioavailability bypass blood-brain barrier (BBB). The drug …
Intranasal delivery and transfection of mRNA therapeutics in the brain using cationic liposomes
Nucleic acid-based therapeutics, including the use of messenger RNA (mRNA) as a drug
molecule, has tremendous potential in the treatment of chronic diseases, such as age …
molecule, has tremendous potential in the treatment of chronic diseases, such as age …
[HTML][HTML] Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment
Messenger RNA (mRNA) recently emerged as an appealing alternative to treat and prevent
diseases ranging from cancer and Alzheimer's disease to COVID-19 with significant clinical …
diseases ranging from cancer and Alzheimer's disease to COVID-19 with significant clinical …
Minimally invasive nasal depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain
S Padmakumar, G Jones, G Pawar, O Khorkova… - Journal of Controlled …, 2021 - Elsevier
The limitations of central nervous system (CNS) drug delivery conferred by the blood-brain
barrier (BBB) have been a significant obstacle in the development of large molecule …
barrier (BBB) have been a significant obstacle in the development of large molecule …
Long-acting therapeutic delivery systems for the treatment of gliomas
S Padmakumar, MM Amiji - Advanced Drug Delivery Reviews, 2023 - Elsevier
Despite the emergence of cutting-edge therapeutic strategies and tremendous progress in
research, a complete cure of glioma remains elusive. The heterogenous nature of tumor …
research, a complete cure of glioma remains elusive. The heterogenous nature of tumor …
Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis
Background Cystatin SN (CST1) and cystatin SA (CST2) are cysteine protease inhibitors that
protect against allergen, viral, and bacterial proteases. Cystatins are overexpressed in the …
protect against allergen, viral, and bacterial proteases. Cystatins are overexpressed in the …
Nucleic acid therapies for CNS diseases: pathophysiology, targets, barriers, and delivery strategies
Nucleic acid therapeutics have emerged as one of the very advanced and efficacious
treatment approaches for debilitating health conditions, including those diseases affecting …
treatment approaches for debilitating health conditions, including those diseases affecting …
The battle of lipid-based nanocarriers against blood-brain barrier: A critical review
KK Abla, MM Mehanna - Journal of Drug Targeting, 2023 - Taylor & Francis
Central nervous system integrity is the state of brain functioning across sensory, cognitive,
emotional-social behaviors, and motor domains, allowing a person to realise his full …
emotional-social behaviors, and motor domains, allowing a person to realise his full …